JORDAN U. GUTTERMAN, M.D.
Osteopathic Medicine at Holcombe Blvd, Houston, TX
License number
Texas D8721
Category
Osteopathic Medicine
Type
Hematology & Oncology
Address
Address
1515 Holcombe Blvd, Houston, TX 77030
Phone
(713) 792-6161
(713) 792-2991
(713) 792-2991
Personal information
See more information about JORDAN U. GUTTERMAN at radaris.comName
Address
Phone
1308 Richmond Ave, Houston, TX 77006
1515 Holcombe Blvd, Houston, TX 77030
1701 Hermann Dr #30G, Houston, TX 77004
41St St, Houston, TX 77001
4848 Pin Oak Park, Houston, TX 77081
Organization information
See more information about JORDAN U. GUTTERMAN at bizstanding.comUniversity TX MD Anderson Cancer Center - Jordan U Gutterman MD
1515 Holcombe Blvd #444, Houston, TX 77030
Categories:
Internal Medicine Physicians & Surgeons
Phone:
(713) 792-2676 (Phone)
Professional information
Jordan U Gutterman, Houston TX
Specialties:
Internist
Address:
1515 Holcombe Blvd, Houston, TX 77030
Education:
Medical College of Virginia - Doctor of Medicine
Durham VA Medical Center - Residency - Family Medicine
Duke University Hospital - Residency - Family Medicine
Durham VA Medical Center - Residency - Family Medicine
Duke University Hospital - Residency - Family Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Hematology (Internal Medicine)
Dr. Jordan U Gutterman - MD (Doctor of Medicine)
Hospitals:
1515 Holcombe Blvd SUITE 41, Houston 77030
MD ANDERSON CANCER CENTER
1515 Holcombe Blvd, Houston 77030
The University of Texas M.D. Anderson Cancer Center
1515 Holcombe Blvd, Houston 77030
1515 Holcombe Blvd SUITE 41, Houston 77030
MD ANDERSON CANCER CENTER
1515 Holcombe Blvd, Houston 77030
The University of Texas M.D. Anderson Cancer Center
1515 Holcombe Blvd, Houston 77030
MD ANDERSON CANCER CENTER
1515 Holcombe Blvd, Houston 77030
The University of Texas M.D. Anderson Cancer Center
1515 Holcombe Blvd, Houston 77030
1515 Holcombe Blvd SUITE 41, Houston 77030
MD ANDERSON CANCER CENTER
1515 Holcombe Blvd, Houston 77030
The University of Texas M.D. Anderson Cancer Center
1515 Holcombe Blvd, Houston 77030
Education:
Medical Schools
Virginia Commonwealth University / Medical College of Virginia School of Medicine
Graduated: 1964
Virginia Commonwealth University / Medical College of Virginia School of Medicine
Graduated: 1964
Triterpene Compositions And Methods For Use Thereof
US Patent:
7985435, Jul 26, 2011
Filed:
Jan 15, 2010
Appl. No.:
12/688651
Inventors:
Charles J. Arntzen - Ithaca NY, US
Mary E. Blake - Tucson AZ, US
Jordan U. Gutterman - Houston TX, US
Joseph J. Hoffmann - Tucson AZ, US
Gamini S. Jayatilake - Broomfield CO, US
David T. Bailey - Boulder CO, US
Mary E. Blake - Tucson AZ, US
Jordan U. Gutterman - Houston TX, US
Joseph J. Hoffmann - Tucson AZ, US
Gamini S. Jayatilake - Broomfield CO, US
David T. Bailey - Boulder CO, US
Assignee:
Research Development Foundation - Carson City NV
International Classification:
A61K 31/704, A61K 31/7034, A61K 36/38, C07H 15/256, A61P 35/00
US Classification:
424757, 536 181, 514 25, 514 33
Abstract:
The invention provides saponin mixtures and compounds which are isolated from the species and methods for their use. These compounds may contain a triterpene moiety, such as acacic or oleanolic acid, to which oligosaccharides and monoterpenoid moieties are attached. The mixtures and compounds have properties related to the regulation of apoptosis and cytotoxicity of cells and exhibit potent anti-tumor effects against a variety of tumor cells.
Avicin Coated Stents
US Patent:
7780974, Aug 24, 2010
Filed:
Sep 20, 2005
Appl. No.:
11/230589
Inventors:
Jordan U. Gutterman - Houston TX, US
Assignee:
Research Development Foundation - Carson City NV
International Classification:
A61F 2/06
US Classification:
424423, 623 115
Abstract:
The invention provides novel compositions and methods related to stents, such as coronary stents, comprising avicins, which are triterpene saponin compositions. In particular aspects of the invention, the avicins have growth-inhibiting properties and/or anti-inflammatory properties. In specific embodiments of the invention, the stent comprising the avicin reduces at least in part restenosis, such as that associated with stent procedures.
Triterpene Compositions And Methods For Use Thereof
US Patent:
8324177, Dec 4, 2012
Filed:
Jun 14, 2011
Appl. No.:
13/160144
Inventors:
Charles J. Arntzen - Ithaca NY, US
Mary E. Blake - Tucson AZ, US
Jordan U. Gutterman - Houston TX, US
Joseph J. Hoffmann - Tucson AZ, US
Gamini S. Jayatilake - Broomfield CO, US
David T. Bailey - Boulder CO, US
Mary E. Blake - Tucson AZ, US
Jordan U. Gutterman - Houston TX, US
Joseph J. Hoffmann - Tucson AZ, US
Gamini S. Jayatilake - Broomfield CO, US
David T. Bailey - Boulder CO, US
Assignee:
Research Development Foundation - Carson City NV
International Classification:
A61K 31/70, C07H 15/24
US Classification:
514 33, 536 181
Abstract:
The invention provides saponin mixtures and compounds which are isolated from the species and methods for their use. These compounds may contain a triterpene moiety, such as acacic or oleanolic acid, to which oligosaccharides and monoterpenoid moieties are attached. The mixtures and compounds have properties related to the regulation of apoptosis and cytotoxicity of cells and exhibit potent anti-tumor effects against a variety of tumor cells.
Triterpene Compositions And Methods For Use Thereof
US Patent:
7670632, Mar 2, 2010
Filed:
Dec 6, 2005
Appl. No.:
11/295189
Inventors:
Charles J. Arntzen - Ithaca NY, US
Mary E. Blake - Tucson AZ, US
Jordan U. Gutterman - Houston TX, US
Mary E. Blake - Tucson AZ, US
Jordan U. Gutterman - Houston TX, US
Assignee:
Research Development Foundation - Carson City NV
International Classification:
A61K 35/78, A61P 9/10
US Classification:
424757, 514821
Abstract:
The invention provides saponin mixtures and compounds which are isolated from the species and methods for their use. These compounds may contain a triterpene moiety, such as acacic or oleanolic acid, to which oligosaccharides and monoterpenoid moieties are attached. The mixtures and compounds have properties related to the regulation of apoptosis and cytotoxicity of cells and exhibit potent anti-tumor effects against a variety of tumor cells.
Inhibition Of Nf-Kappab By Triterpene Compositions
US Patent:
2006014, Jul 6, 2006
Filed:
Nov 16, 2001
Appl. No.:
09/992556
Inventors:
Jordan Gutterman - Houston TX, US
Valsala Haridas - Houston TX, US
Valsala Haridas - Houston TX, US
International Classification:
A61K 31/704, A61K 31/215, A61K 31/20
US Classification:
514033000, 514559000, 514529000
Abstract:
The invention provides methods for the inhibition of inflammation by providing, to a cell, in need thereof, monoterpene compositions that inhibit NF-κB. These compositions may also contain a carrier moiety that renders the monoterpene composition membrane permeable. The carrier may include triterpenoid moieties, sugars, lipids, or even additional monoterpenoid moieties. The composition can also contain additional chemical functionalities. Methods for using these compounds to prevent and treat a wide range of inflammatory conditions, especially, premalignant inflammatory conditions are described.
Triterpene Compositions And Methods For Use Thereof
US Patent:
7105186, Sep 12, 2006
Filed:
Sep 9, 2002
Appl. No.:
10/238647
Inventors:
Charles J. Arntzen - Ithaca NY, US
Mary E. Blake - Tucson AZ, US
Jordan U. Gutterman - Houston TX, US
Mary E. Blake - Tucson AZ, US
Jordan U. Gutterman - Houston TX, US
Assignee:
Research Development Foundation - Carson City NV
International Classification:
A61K 35/78, C12N 5/10, C12N 5/00, C12P 19/44, A01N 43/04
US Classification:
424757, 435419, 435420, 435 74, 514 25
Abstract:
The invention provides saponin mixtures and compounds which are isolated from the species and methods for their use. These compounds may contain a triterpene moiety, such as acacic or oleanolic acid, to which oligosaccharides and monoterpenoid moieties are attached. The mixtures and compounds have properties related to the regulation of apoptosis and cytotoxicity of cells and exhibit potent anti-tumor effects against a variety of tumor cells.
Compositions For The Reversible Thioesterification Of Signaling Proteins And Methods Of Using Same
US Patent:
2007006, Mar 22, 2007
Filed:
Jul 18, 2006
Appl. No.:
11/488992
Inventors:
Jonathan Stamler - Chapel Hill NC, US
Jordan Gutterman - Houston TX, US
Jordan Gutterman - Houston TX, US
International Classification:
A61K 31/704, C07H 15/24, C12Q 1/26, C12P 33/00, C12N 5/08, C12N 1/21
US Classification:
514033000, 536018100, 435025000, 435252300, 435325000, 435366000, 435052000
Abstract:
Avicins and other thioesterification agents are used to modify cysteine groups of signaling proteins in order to modify their activity. Pathologies associated with signaling proteins which are regulatable through this method are treated using these thioesterification agents. These pathologies include those involving proteins which modulate physiologic redox status of organisms including arthersclerosis, cancer, bacterial infection, inflammation, and neurological disorders.
Triterpene Compositions And Methods For Use Thereof
US Patent:
6962720, Nov 8, 2005
Filed:
Nov 30, 2001
Appl. No.:
10/000720
Inventors:
Valsala Haridas - Houston TX, US
Jordan U. Gutterman - Houston TX, US
Jordan U. Gutterman - Houston TX, US
Assignee:
Research Development Foundation - Carson City NV
International Classification:
A61K035/78
US Classification:
424757, 514886, 514887
Abstract:
The invention provides novel saponin mixtures and compounds which are isolated from the species and methods for their use. These compounds may contain a triterpene moiety, such as acacic or oleanolic acid, to which oligosaccharides and monoterpenoid moieties are attached. The mixtures and compounds have properties related to the regulation of apoptosis and cytotoxicity of cells and exhibit potent anti-tumor effects against a variety of tumor cells.